BIOCIRCUIT TECHNOLOGIES, INC.

ATLANTA, GA · Founded 2016 · CIK 0001777259 · Medtech · Private

Nerve Tape®, a biologic wrap with integrated microscale Nitinol microhooks for sutureless nerve repair

biocircuit.com →
Grants
$2.7M
3 awards
Sector median: 1
Raised
$14M
3 Form D · Oct 2022
48 months since last filing
Contracts
—
No federal contracts on record
Patents
4
2 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Microhook nerve tape: A nerve repair coaptation aid$531,286
Private capital raised· 1 of 2 same dayForm D · SEC$1,500,000
Private capital raised· 2 of 2 same dayForm D · SEC$3,150,000
Private capital raisedForm D · SEC$9,000,000
Federal grantDepartment of Health and Human Services · Phase II · Line extension and expanded preclinical evidence for Nerve Tape, a sutureless nerve repair coaptation device$1,188,158
Federal grantDepartment of Health and Human Services · Phase II · Line extension and expanded preclinical evidence for Nerve Tape, a sutureless nerve repair coaptation device$956,147
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1238ADVANCED MEDICAL DEVICE TECHNOLOGIES, INC.——
1239DYNOCARDIA, INC.—$2.9M
1240ACTUS INTERACTIVE SOFTWARE LLC—$243K
1241BIOCIRCUIT TECHNOLOGIES, INC.—$14M
1242APC AVE 20, LLC—$1.7M
1243Revelle Aesthetics, Inc.—$25M
1244VST Operating Corp.—$1.7M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Michelle JarrardDirector · Executive Officer
  • Michael MastersDirector
  • James NahirnyDirector
  • Thomas O'BrienDirector · Executive Officer

Patents

USPTO · 2 granted of 4

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.